Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 4/2009

01.08.2009 | Research Article

Prescribing errors in patients with documented drug allergies: comparison of ICD-10 coding and written patient notes

verfasst von: Arwa Benkhaial, Jens Kaltschmidt, Elke Weisshaar, Thomas L. Diepgen, Walter E. Haefeli

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction: Allergies to drugs are a major cause for hospitalisation and inappropriate prescriptions to patients. However, allergies can be prevented if the patient’s history of drug allergy is known and coded. Objective of the study: Assessment of the value of the widely used ICD-10 codes for drug-allergies (e.g. Z88, L27) as triggers for decision support in an electronic prescription system and evaluation of the potential impact of such an alert system. We also evaluated the usefulness of manual drug allergy notes recorded in patients’ charts in the prevention of prescribing errors due to drug allergies. Setting: University hospital providing primary and tertiary care. Methods: Using Anatomical Therapeutic Chemical (ATC) classification codes we allocated to drug specifying ICD-10 codes (i.e. Z88) all drugs belonging to the same group of compounds or those known to induce cross-allergy. In a randomly selected cohort of 200 in-patients we then assessed documentation and coding of drug allergies and incident prescribing errors ignoring patients’ drug allergies. Results: Eighteen of the 200 patients had an allergy-related ICD code in the chart, 51 had a written note, and 13 had both. About 21% of patients with documented drug allergies were prescribed a drug potentially triggering the allergy. There was no difference in prescribing errors due to drugs potentially inducing allergies when the allergy was only documented as an ICD-10 code or the information was available in the paper record (P > 0.05). Conclusion: The findings of this study emphasise the necessity of a more precise and efficient documentation system of drug allergies along with the implementation of an electronic CDS for drug allergies that makes physicians aware of patients’ drug allergies during the prescribing process.
Literatur
1.
Zurück zum Zitat Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol. 2004;113:832–6. doi:10.1016/j.jaci.2003.12.591.CrossRefPubMed Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol. 2004;113:832–6. doi:10.​1016/​j.​jaci.​2003.​12.​591.CrossRefPubMed
4.
6.
Zurück zum Zitat Thong BY, Leong KP, Tang CY, Chng HH. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol. 2003;90:342–7.CrossRefPubMed Thong BY, Leong KP, Tang CY, Chng HH. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol. 2003;90:342–7.CrossRefPubMed
11.
12.
Zurück zum Zitat Bates DW, Teich JM, Lee J, Seger D, Kuperman GJ, Ma’Luf N, et al. The impact of computerised physician order entry on medication error prevention. J Am Med Inform Assoc. 1999;6:313–21.CrossRefPubMedPubMedCentral Bates DW, Teich JM, Lee J, Seger D, Kuperman GJ, Ma’Luf N, et al. The impact of computerised physician order entry on medication error prevention. J Am Med Inform Assoc. 1999;6:313–21.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Brunton LL, Lazo JS, editors. Goodman and Gilman’s: the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. ISBN: 0-07-142280-3. Brunton LL, Lazo JS, editors. Goodman and Gilman’s: the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. ISBN: 0-07-142280-3.
18.
Zurück zum Zitat Pichichero ME. Cephalosporins can be prescribed safely for penicillin-allergic patients. J Fam Pract. 2006;55:106–12.PubMed Pichichero ME. Cephalosporins can be prescribed safely for penicillin-allergic patients. J Fam Pract. 2006;55:106–12.PubMed
20.
Zurück zum Zitat Prescott WA, DePestel DD, Ellis JJ, Regal RE. Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy. Clin Infect Dis. 2004;38:1102–7. doi:10.1086/382880.CrossRefPubMed Prescott WA, DePestel DD, Ellis JJ, Regal RE. Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy. Clin Infect Dis. 2004;38:1102–7. doi:10.​1086/​382880.CrossRefPubMed
21.
24.
Zurück zum Zitat Saxon A, Hassner A, Swabb EA, Wheeler B, Adkinson F Jr. Lack of cross-reactivity between aztreonam, a monobactam antibiotic, and penicillin in penicillin-allergic subjects. J Infect Dis. 1984;149:16–22.CrossRefPubMed Saxon A, Hassner A, Swabb EA, Wheeler B, Adkinson F Jr. Lack of cross-reactivity between aztreonam, a monobactam antibiotic, and penicillin in penicillin-allergic subjects. J Infect Dis. 1984;149:16–22.CrossRefPubMed
25.
Zurück zum Zitat Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, et al. Absence of cross-reactivity between sulphonamide antibiotics and sulphonamide nonantibiotics. N Engl J Med. 2003;349:1628–35. doi:10.1056/NEJMoa022963.CrossRefPubMed Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, et al. Absence of cross-reactivity between sulphonamide antibiotics and sulphonamide nonantibiotics. N Engl J Med. 2003;349:1628–35. doi:10.​1056/​NEJMoa022963.CrossRefPubMed
29.
Zurück zum Zitat Wasserman MJ, Weber DA, Guthrie JA, Bykerk VP, Lee P, Keystone EC. Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number. J Rheumatol. 2004;31:1912–7.PubMed Wasserman MJ, Weber DA, Guthrie JA, Bykerk VP, Lee P, Keystone EC. Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number. J Rheumatol. 2004;31:1912–7.PubMed
31.
Zurück zum Zitat Cantrill JA, Cottrell WN. Accuracy of drug allergy documentation. Am J Health Syst Pharm. 1997;54:1627–9.PubMed Cantrill JA, Cottrell WN. Accuracy of drug allergy documentation. Am J Health Syst Pharm. 1997;54:1627–9.PubMed
36.
Zurück zum Zitat Wipple JK, Ausman RK, Quebbman EJ. Narcotic use in the hospital: reasonably safe? Ann Pharmacother. 1992;26:897–901.CrossRef Wipple JK, Ausman RK, Quebbman EJ. Narcotic use in the hospital: reasonably safe? Ann Pharmacother. 1992;26:897–901.CrossRef
37.
Zurück zum Zitat Apter AJ, Kinman J, Bilker WB, Herlim M, Margolis DJ, Lautenbach E, et al. Is there cross-reactivity between penicillins and cephalosporins? Am J Med. 2006;119:354.e11–20.CrossRef Apter AJ, Kinman J, Bilker WB, Herlim M, Margolis DJ, Lautenbach E, et al. Is there cross-reactivity between penicillins and cephalosporins? Am J Med. 2006;119:354.e11–20.CrossRef
38.
Zurück zum Zitat Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol. 1995;74:167–70.PubMed Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol. 1995;74:167–70.PubMed
39.
Zurück zum Zitat Romano A, Guéant-Rodriguez RM, Viola M, Pettinato R, Guéant JL. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med. 2004;141:16–22.CrossRefPubMed Romano A, Guéant-Rodriguez RM, Viola M, Pettinato R, Guéant JL. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med. 2004;141:16–22.CrossRefPubMed
42.
Zurück zum Zitat Quinzler R, Schmitt SPW, Szecsenyi J, Haefeli WE. Optimizing information on drug exposure by collection of package code information in questionnaire surveys. Pharmacoepidemiol Drug Saf. 2007;16:1024–30. doi:10.1002/pds.1406.CrossRefPubMed Quinzler R, Schmitt SPW, Szecsenyi J, Haefeli WE. Optimizing information on drug exposure by collection of package code information in questionnaire surveys. Pharmacoepidemiol Drug Saf. 2007;16:1024–30. doi:10.​1002/​pds.​1406.CrossRefPubMed
43.
Zurück zum Zitat Adkinson NF Jr. Drug allergy. In: Adkinson NF Jr., Bochner BS, editors. Middleton’s allergy principles and practice. vol. II, 6th ed. Philadelphia: Mosby; 2003. pp. 1679–94. ISBN: 0-323-01425-9. Adkinson NF Jr. Drug allergy. In: Adkinson NF Jr., Bochner BS, editors. Middleton’s allergy principles and practice. vol. II, 6th ed. Philadelphia: Mosby; 2003. pp. 1679–94. ISBN: 0-323-01425-9.
44.
Zurück zum Zitat Yates AB, deShazo RD. Drug allergies and hypersensitivity. In: Rich RR, Fleisher TA, editors. Clinical immunology: principles & practice. 2nd ed. London: Mosby; 2001. Pp. 54.1–15. ISBN: 0 7234 3161 2. Yates AB, deShazo RD. Drug allergies and hypersensitivity. In: Rich RR, Fleisher TA, editors. Clinical immunology: principles & practice. 2nd ed. London: Mosby; 2001. Pp. 54.1–15. ISBN: 0 7234 3161 2.
Metadaten
Titel
Prescribing errors in patients with documented drug allergies: comparison of ICD-10 coding and written patient notes
verfasst von
Arwa Benkhaial
Jens Kaltschmidt
Elke Weisshaar
Thomas L. Diepgen
Walter E. Haefeli
Publikationsdatum
01.08.2009
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 4/2009
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-009-9300-5

Weitere Artikel der Ausgabe 4/2009

International Journal of Clinical Pharmacy 4/2009 Zur Ausgabe

Editorial

Editorial

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.